Silgan Holdings Inc. (SLGN) Q3 2026 earnings review
Silgan raises its profit outlook, but Dispensing profit falls again
Silgan earned more per share while customers bought fewer cans and closures, and it announced the purchase of Trivium. Sales rose 2%, mostly from passing higher material costs to customers. Profit per share excluding one-offs reached $1.31, the top of the company's range, because Metal Containers earned more on each can.
| Sales | $2.04B +1.6% from a year ago |
|---|---|
| Profit per share, excluding one-offs | $1.31 +7% from a year ago; top of the $1.21–1.31 range |
| Profit per share, as reported | $0.99 −7% from a year ago; below the $1.05–1.15 range |
| Full-year outlook, profit per share excluding one-offs | Raised $0.05 at the middle $3.83–3.93, about 4% above 2025 |
⚖️ Verdict: ⚪ Neutral
The case is unchanged, because the higher full-year outlook only passes this quarter's extra profit through and leaves the fourth-quarter plan where it was. The bad news: Dispensing profit fell for a third quarter in a row, and reported profit missed its range because of deal and restructuring costs. The release also gives no price for Trivium.
The question now is whether Dispensing profit can grow in the fourth quarter while Silgan takes on Trivium. Either pharma and fragrance products lift the segment once cost pass-throughs catch up, or soft closures demand keeps profit falling. By our math the outlook needs Dispensing profit about 6% above last year's fourth quarter, so that segment line will settle it.
🐂 Bull Case
Metal Containers Profit Rose 10% on Fewer Cans
Metal Containers makes steel and aluminum cans for pet food, soup, fruit and vegetables, and it brings in more than half of Silgan's sales. This quarter it shipped 4% fewer cans, because soup customers bought less while pet food and vegetable packers bought more. Profit before interest and tax, excluding one-offs, still rose 10% to $105 million.
- Sales: $1.17 billion, up 1% from a year ago
- Profit margin excluding one-offs: 9.0% of sales, up 0.7 percentage points
- Same margin three months earlier: down 1.9 points from a year ago
- Segment sales growth: 13% in the spring quarter, 1% now, as steel cost pass-through faded
The company credited "more favorable price/cost including mix": its prices caught up with steel and aluminum costs, and the cans it sold carried more profit each. That reverses the spring, when tariff-driven steel costs passed to customers inflated sales but diluted the margin. Fewer cans means the gain came from price, so it depends on customers accepting current prices rather than on demand.
What to watch: the Metal Containers margin in the fourth quarter, when the vegetable pack is over and soup carries the volume. A margin above the 6.5% of a year earlier would show the price recovery holds without the seasonal pack.
Silgan's Third-Quarter Plan Was Cautious
In July Silgan set a range of $1.21 to $1.31 for third-quarter profit per share excluding one-offs. It landed at $1.31, the top, and the company lifted the bottom of its full-year range by $0.10 to match. By our math the new fourth-quarter range equals what the July full-year range already implied, so the view of the fourth quarter did not change.
The beat sits at the high end of the pattern, not outside it: results averaged 2.3% above the middle over the last four quarters. So the raise says the July plan was careful, not that demand improved, because volumes fell in two of three segments.
What to watch: fourth-quarter profit per share against its $0.76 to $0.86 range, set with the vegetable pack complete. A result at the top again would mean the full-year plan carried a cushion all year.
Pharma Dispensing Products Grew Double Digits
Dispensing and Specialty Closures makes pumps, sprayers and caps for perfume, food, drinks and medicines. Chief executive Adam Greenlee wants this "high value, higher growth dispensing business" to expand "both organically and through continued returns-based investments", and devices that deliver prescription drugs grew fastest this quarter.
Pharma dispensing products grew double digits in North America, and Greenlee said "our teams exceeded expectations for shipments of pharma drug delivery products". Fragrance grew mid-single digits. Together they held the segment's unit volumes level with a year ago while standard food and beverage closures sold less, and these lines sell at higher prices than standard caps.
What to watch: whether Silgan discloses pharma and fragrance revenue with its fourth-quarter results, which it has not done so far. A figure would show whether the growth lines can outweigh closures that sell less.
🐻 Bear Case
Dispensing Profit Fell Again as Pass-Throughs Lagged
Dispensing and Specialty Closures is Silgan's most profitable segment and the one it most wants to expand. Its profit before interest and tax, excluding one-offs, fell 2% to $111 million. The company blamed "the delayed pass through of inflation in manufacturing costs including freight and applicable surcharges" and "less favorable manufacturing efficiency".
- Profit margin excluding one-offs: 15.9% of sales, down 0.5 percentage points
- Profit change from a year ago: −3% in the first quarter, −0.3% in the second, −2% now
- Sales: $699 million, up 1%, with 3 points from cost pass-through and 1 point lost to mix
- Unit volumes: level with a year ago; fragrance up mid-single digits after mid-teens a year earlier
This matters because the full-year outlook says profit will exceed 2025 in every segment. After nine months Dispensing is $6 million behind last year. So by our math its fourth-quarter profit must reach about $105 million, 6% above a year ago, after three quarters without growth, while fragrance growth has slowed each quarter since last autumn.
What to watch: Dispensing profit in the fourth-quarter release against the $105 million it needs. A lower figure would mean the outlook failed in the segment Silgan most wants to grow, and that the cost pass-through lag lasted more than one quarter.
Reported Profit Fell Short of Silgan's Own Range
Silgan reports two profit figures. The one in the headline, $1.31 a share, leaves out costs the company treats as one-offs. The one under US accounting rules, $0.99 a share, fell 7% from a year ago. It landed below the $1.05 to $1.15 range set in July, while the adjusted figure reached the top of its own range.
- Trivium deal fees: $10.3 million, excluded from adjusted profit; none a year ago
- Restructuring charges: $17.1 million, against $5.8 million estimated in July and $7.2 million a year ago
- Corporate costs excluding deal fees: $5.1 million, down from $11.0 million, supplying $5.9 million of the $13.6 million rise in adjusted profit before interest and tax
- The three operating segments together: adjusted profit up 3%, against 6% for the group total
The distinction matters because both excluded items cost cash and both recur. Silgan calls restructuring "an investment to generate savings rather than period costs", yet the charges reached $44 million in nine months against $28 million a year earlier. By our math the deal fees alone equal about 7 cents a share after tax, so had the company counted them, profit per share would sit near $1.24, below the middle of the range.
What to watch: the fourth-quarter restructuring charge, which Silgan estimates at $2.5 million, with $7.5 million more of deal fees. A charge far above that estimate would put the full-year reported profit range of $2.89 to $2.99 at risk, as happened with the July range.
Silgan Announces Trivium Deal, Discloses No Price
The results release opens with "transformative portfolio acceleration through the acquisition of Trivium", and chief executive Adam Greenlee says Silgan will "reposition our segments" around it. The release gives no purchase price, no financing plan and no closing date, so a reader cannot tell what the deal does to the balance sheet.
That balance sheet carries $4.55 billion of debt against $325 million of cash. Debt is 8% below a year ago because the packaging group repaid borrowings instead of buying back shares, which it has not done at all this year. Deal fees cost $10.3 million this quarter, and the company expects $7.5 million more in the fourth quarter.
What to watch: the price and funding in the deal filings, and year-end debt. A purchase funded mostly with new borrowing would undo the $400 million of debt reduction since last September.
Risks This Quarter Did Not Answer
Five standing concerns got a partial reading or none in the results release, because Silgan gives few volume figures beyond segment totals and names no numbers for its individual product lines.
- Fourth-quarter dependence: the full-year outlook still needs profit per share up 21% in the fourth quarter, against a base when the adjusted tax rate ran 31.5%; the fourth-quarter release settles it.
- Metal Containers margin dilution: paused this quarter as prices caught up with costs, but on fewer cans; the fourth-quarter margin without the vegetable pack would move it.
- Pet food volumes: the release says they rose but gives no rate, after 7% in the spring and 11% in the winter; any disclosed figure would move it.
- Custom Containers volumes: down 8%, about 5% beyond the planned business exits by our math, against a spring plan of full-year volume growth; fourth-quarter volume would move it.
- Forecasting: Greenlee said volumes came in more muted than the company anticipated, the sixth quarter in a row with a new headwind; the fourth-quarter result against its range would move it.
👓 Other Themes
Customers Bought Less Than Silgan Expected
Chief executive Adam Greenlee said "challenging consumer conditions have led to more muted volumes than we initially anticipated", and the release lists where: soup cans, food and beverage closures in Europe and North America, and non-exit volume in Custom Containers. Sales still grew because contracts pass higher material costs to customers, so Silgan's revenue tracks steel and resin prices more than the number of units its customers buy.
💲 Other KPIs
Up 8.3% from a year ago while sales rose 1.6%, so customers owe Silgan more per dollar of sales. The nine-month cash tied up in receivables rose by $189 million from a year earlier. That is the main reason operating cash flow for nine months ran $82 million below last year even though inventories released cash.
Down 10% from a year ago and $163 million below year-end, so the can maker holds less stock per dollar of sales than at any point in two years. Inventories released $153 million of cash over nine months, against a $57 million build a year earlier. The release does not split raw materials from finished goods.
Debt less cash fell 7% from a year ago, by our math, and quarterly interest expense dropped $2.7 million on lower average borrowings. Interest has fallen from a year earlier in each of the last three quarters. The Trivium purchase will change both lines; the release does not say by how much.
🔮 Guidance
Raised. The bottom of the range moved up $0.10. The middle is now $3.88, about 4% above last year. The move equals this quarter's result above the middle of its own range, so the view of the fourth quarter did not change. Third move in four quarters, each small: +$0.03, unchanged, +$0.05. Deal fees and restructuring sit outside this figure, so the raise does not depend on them.
New. The middle of the range is $0.81, 21% above the fourth quarter of 2025. That base was weak. A tax rate above 31% and customer destocking had cut profit per share to $0.67 then, so most of the planned growth is the comparison. By our math the range is exactly what the July full-year outlook implied once this quarter is known, and against the fourth quarter of 2024 the middle sits about 5% lower.
Unchanged. After nine months Metal Containers is ahead of last year and Custom Containers is level, so the line rests on Dispensing, which is behind. By our math Dispensing must earn about 6% more than a year ago in the fourth quarter to clear the bar, while Metal Containers could fall 11% and still finish the year higher. Custom Containers must at least match its $17 million from last year's fourth quarter.
Unchanged. Nine-month operating cash flow less capital spending is $76 million behind last year, mostly because receivables absorbed more cash. So by our math the fourth quarter must deliver about $1.33 billion on that basis, roughly $100 million more than the fourth quarter of 2025. The record supports the figure: Silgan set the same target for 2025 and delivered $445 million.
Unchanged. Nine-month spending is $230 million, or 4.4% of sales. That leaves about $80 million for the fourth quarter, in line with the pace of the first three. The figure has stood since the company first gave it with its 2025 results, and chief executive Adam Greenlee links it to the "returns-based investments" in the dispensing business.
Cut. Reported profit per share now falls below the $3.00 floor set in July. The company added $17.8 million of Trivium deal fees for the year and raised its restructuring estimate to $46.8 million. The middle of the range is 5% below the July view but still above last year's $2.70, which carried a larger restructuring bill.
New. The middle of the range is $0.63, against $0.17 a year ago. The comparison is easy. Last year's fourth quarter carried a $32.5 million restructuring charge and a 67% tax rate. The plan assumes only $2.5 million of restructuring and $7.5 million of deal fees this time, so reported and adjusted profit sit closer together than in any quarter this year.
❓ Key Questions
What will Silgan pay for Trivium, and how?
The release calls the deal transformative but gives no price, funding mix or closing date. With $4.55 billion of debt and no buybacks this year, the answer decides whether the debt reduction of the last year reverses.
How much revenue do pharma and fragrance dispensing make?
Both lines grew this quarter while the segment's profit fell. Without their revenue and margin, readers cannot tell whether the growth lines are large enough to outweigh soft food and beverage closures.
What do the $17 million restructuring charges save?
Charges nearly tripled the July estimate and total $44 million for nine months, yet the plan assumes only $2.5 million in the fourth quarter. The savings target and the plants involved would show whether the spending ends.
Why has Silgan bought back no shares this year?
Repurchases were $59 million at this point last year and zero now, while deal costs rose. The answer shows whether capital is reserved for Trivium or for further purchases.
How much did pet food volumes grow this quarter?
Pet food is more than half of Metal Containers volume and grew 7% in the spring. The release says it rose but gives no rate, so the slowdown risk cannot be read.